Skip to main content
. 2021 Jun 14;11:668632. doi: 10.3389/fcimb.2021.668632

Table 3.

List of the AMPs in ongoing clinical trials.

AMP Peptide structural characteristic Ongoing Clinical Trials
Bacitracin Natural cyclic peptide Phase IV
Pexiganan Natural linear peptide Phase III
Omiganan Indolicidin derivative peptide Phase III
LL-37 Natural α-helical peptide Phase II
LTX-109 Synthetic Antimicrobial Peptidomimetic Phase II
Brilacidin Synthetic peptide Phase II